In March 2026, the Hong Kong Stock Exchange (Exchange) launched a public consultation to seek market feedback on its proposed reforms to enhance its listing framework.
Since 2018, the Exchange has introduced a series of reforms, including listing regimes for Biotech Companies, companies with weighted voting right (WVR) structures, special purpose acquisition companies (SPACs) and early stage Specialist Technology Companies, as well as measures to facilitate the secondary listing of issuers listed overseas. These initiatives were designed to (i) attract high quality companies in new economy sectors and (ii) encourage Greater China issuers listed in the United States to consider listing in Hong Kong. The reforms have had a profound impact. By the end of 2025, new economy industries accounted for 48.2% of total market capitalisation and 59.4% of market turnover, compared with 14.6% of market capitalisation and 21.6% of turnover prior to 2017. Nevertheless, the Exchange has received requests from stakeholders for further market enhancements, including measures to achieve the aforementioned objectives, which has led this consultation.
The Exchange’s proposed enhancements are summarised below.















